Quinfamide
CAS No. 62265-68-3
Quinfamide ( WIN-40014 )
Catalog No. M26803 CAS No. 62265-68-3
Quinfamide is a compound with the potential to treat tropical parasitic infections such as Amoebiasis and Helminthiasis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 199 | Get Quote |
|
10MG | 285 | Get Quote |
|
25MG | 510 | Get Quote |
|
50MG | 732 | Get Quote |
|
100MG | 1017 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameQuinfamide
-
NoteResearch use only, not for human use.
-
Brief DescriptionQuinfamide is a compound with the potential to treat tropical parasitic infections such as Amoebiasis and Helminthiasis.
-
DescriptionQuinfamide is a compound with the potential to treat tropical parasitic infections such as Amoebiasis and Helminthiasis.
-
SynonymsWIN-40014
-
PathwayOthers
-
TargetOther Targets
-
RecptorHIF-2α
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number62265-68-3
-
Formula Weight354.2
-
Molecular FormulaC16H13Cl2NO4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESClC(Cl)C(=O)N1CCCc2cc(OC(=O)c3ccco3)ccc12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Xu R, et al. 3-[(1S,2S,3R)-2,3-Difluoro-1-hydroxy-7-methylsulfonylindan-4-yl]oxy-5-fluorobenzonitrile (PT2977), a Hypoxia-Inducible Factor 2α (HIF-2α) Inhibitor for the Treatment of Clear Cell Renal Cell Carcinoma. J Med Chem. 2019 Aug 8;62(15):6876-6893.
molnova catalog
related products
-
Sauchinone
Sauchinone is a useful adjunctive treatment for bacterial infection. Sauchinone, an active lignan found in Saururus chinensis, to regulate the activation of HSCs, to prevent liver fibrosis, and to inhibit oxidative stress in vivo and in vitro.
-
CEP dipeptide 1
CEP dipeptide 1 is a CEP dipeptide with potent angiogenic activity; mediators of age-related macular degeneration (AMD).
-
Trans-caffeic acid
Trans-caffeic acid stearyl ester is posited to inhibit melanogenesis signaling while suppressing cAMP levels and, subsequently, MC1R, MITF, tyrosinase, TRP-2 and TRP-1 down-regulation, resulting in the suppression of tyrosinase activity, DOPA oxidase activity and melanin synthesis.